Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Pentaborate Pentahydrate Hydrogel for Diabetic Foot Wounds
NCT02241811Phase 1Unknown
- Sponsor
- Istanbul Education Research Hospital
- Start
- Sep 2014
- Primary completion
- Dec 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, randomised trial of sodium pentaborate pentahydrate in diabetic foot ulcer (DFU) (2 arms), sponsored by Istanbul Education Research Hospital. Primary endpoints: Wound healing at 2 months and Complication at 2 months. Status: unknown.
02
Drugs
sodium pentaborate pentahydrate
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02241811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241811.